| CTRI Number |
CTRI/2024/09/074311 [Registered on: 25/09/2024] Trial Registered Prospectively |
| Last Modified On: |
05/05/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Probiotic Dentistry |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
Effects of probiotics on oral microorganisms causing dental caries |
|
Scientific Title of Study
|
Comparative evaluation of Probiotic Streptococcus salivarius K12 and M18 lozenges on salivary Streptococcus mutans and Lactobacillus counts in school going children: A Randomized Controlled Trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Dipanshu Kumar |
| Designation |
Assistant Professor |
| Affiliation |
Department of Dentistry, AIIMS, Gorakhpur |
| Address |
OPD Room no 4, Department of Dentistry, AIIMS, Gorakhpur
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
9013190478 |
| Fax |
|
| Email |
drdipanshu.kumar@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Dipanshu Kumar |
| Designation |
Assistant Professor |
| Affiliation |
Department of Dentistry, AIIMS, Gorakhpur |
| Address |
OPD Room no 4, Department of Dentistry, AIIMS, Gorakhpur
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
9013190478 |
| Fax |
|
| Email |
drdipanshu.kumar@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Dipanshu Kumar |
| Designation |
Assistant Professor |
| Affiliation |
Department of Dentistry, AIIMS, Gorakhpur |
| Address |
OPD Room no 4, Department of Dentistry, AIIMS, Gorakhpur
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
9013190478 |
| Fax |
|
| Email |
drdipanshu.kumar@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Dentistry, AIIMS, Gorakhpur, Uttar Pradesh, 273008 |
|
|
Primary Sponsor
|
| Name |
Dr Dipanshu Kumar |
| Address |
Room no 4, Dept of Dentistry, AIIMS, Gorakhpur, UP 273008 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Dipanshu Kumar |
AIIMS, Gorakhpur |
OPD room no 4, Department Of Dentistry Gorakhpur UTTAR PRADESH |
9013190478
drdipanshu.kumar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IHEC, AIIMS, Gorakhpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Children aged 6-12 years visiting Dentistry OPD |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Preventive dental care |
Dental caries is one of the most prevalent chronic diseases affecting both adults and children globally. Probiotics have emerged as a promising intervention for oral health, particularly in the prevention and management of dental caries. This study aims to evaluate and compare the effects of Streptococcus salivarius K12 & M18 probiotic lozenges on the pH, buffering capacity, counts of S. mutans and Lactobacillus in the saliva of children aged 6 to 12 years. |
| Comparator Agent |
Streptococcus salivarius K12 probiotic lozenges |
Oral lozenges containing 2.5 billion Streptococcus salivarius K12 strain |
| Comparator Agent |
Streptococcus salivarius M18 probiotic lozenges |
Oral lozenges containing 2.5 billion Streptococcus salivarius M18 strain |
| Comparator Agent |
Sugarfree candies |
Isomalt based sugarfree candies containg no added sugar used for control/placebo |
|
|
Inclusion Criteria
|
| Age From |
6.00 Year(s) |
| Age To |
12.00 Year(s) |
| Gender |
Both |
| Details |
1. Children aged 6 to 12 years with or without dental caries.
2. Participants must be in good general health as determined by a medical history and physical examination.
3. Parents or guardians must provide written informed consent, and children must provide assent.
|
|
| ExclusionCriteria |
| Details |
Children who have taken antibiotics or probiotics within the past 4 weeks.
Children with any chronic illness or condition that could affect oral health or saliva production
Children with a history of allergies to probiotics or any components of the lozenges or gummies.
Children who are unable to comply with the study protocol, including regular attendance for follow-up visits.
Children with a history of chronic use of medications that may affect oral flora, such as long-term steroid therapy. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The change in the counts of Streptococcus mutans and Lactobacillus in saliva |
1. Baseline
2. 1-hour post consumption
3. After 7 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. The change in the pH and buffering capacity of saliva from baseline to 1-hour post consumption and after 7 days.
2. Adherence to and acceptability of the interventions, assessed through participant and caregiver reports and pill counts. |
1. Baseline
2. 1-hour post consumption
3. After 7 days |
|
|
Target Sample Size
|
Total Sample Size="75" Sample Size from India="75"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
01/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
According to the Global Burden of Disease Study 2017, oral diseases affect approximately 3.5 billion people worldwide, with dental caries being the most common condition. In children, especially those aged 6 to 12 years, dental caries can cause pain, difficulty eating, and disrupted sleep, adversely affecting their overall quality of life and development. Therefore, there is a critical need for effective preventive and management strategies for dental caries in this age group. Probiotics have emerged as a promising intervention for oral health, particularly in preventing and managing dental caries. Probiotics are live microorganisms that confer health benefits to the host when administered in adequate amounts. They work by modulating the oral microbiota, inhibiting the growth of pathogenic bacteria like S. mutans, and promoting a balanced microbial ecosystem. Among various probiotic strains, Streptococcus salivarius K12 has shown potential in reducing S. mutans levels and improving oral health. Additionally, combinations of multiple probiotic strains are being investigated for their synergistic effects on oral health. This study aims to evaluate and compare the effects of Streptococcus salivarius K12 & M18 lozenges on the counts of S. mutans and Lactobacillus in the saliva of children aged 6 to 12 years. By understanding the efficacy of these probiotics, this research hopes to contribute to the development of effective strategies for the prevention and management of dental caries in school going children. |